OOS Investigations: Phase 2 Full-Scale Investigation and Batch Impact Assessment
OOS Investigations: Phase 2 Full-Scale Investigation and Batch Impact Assessment Comprehensive Guide to Phase 2 OOS Investigations and Batch Impact Assessment in Pharmaceutical QMS Out-Of-Specification (OOS) results are critical deviations within a pharmaceutical quality system (QMS) that require immediate and methodical investigation to ensure patient safety, product quality, and compliance with regulatory expectations. Phase 2,…
Read More “OOS Investigations: Phase 2 Full-Scale Investigation and Batch Impact Assessment” »